AmerisourceBergen

AmerisourceBergen Corp. has made organizational changes, effective September 1, 2009. Steven H. Collis has been named executive vice president and president of AmerisourceBergen Drug Corporation (ABDC), the company’s largest subsidiary. Mr. Collis was previously executive vice president and president of AmerisourceBergen Specialty Group (ABSG). In his new role, he will lead the ABDC organization and will continue to report to R. David Yost, president and chief executive officer of AmerisourceBergen.

Michael D. DiCandilo continues as executive vice president and chief financial officer of AmerisourceBergen, with responsibility for all corporate financial operations, supply chain management, AmerisourceBergen Packaging Group, and information technology. He continues to report to Mr. Yost.

Michael A. Mullen will lead ABSG as chief operating officer, AmerisourceBergen Specialty Group, also reporting to Mr. Yost. Mr. Mullen previously served as president of distribution services at ABSG, and as the chief financial officer for the subsidiary.

“ABDC has been very successful since we began running it with Mike DiCandilo leading operations and me leading sales and marketing,” said Mr. Yost. “To drive future performance, we are consolidating those functions under one leader, and I am very pleased that Steve Collis will be applying his substantial management talent to lead ABDC. At the same time, Mike DiCandilo will continue his corporate role with ABDC in finance, supply chain management and our very important Business Transformation ERP project. The result will be an even more focused organization.”

Sign up today for Contracting & Outsourcing 2009!
http://contractpharma.com/2009conference